ROBERT F. JOHNSTON, M.D.; PHILIP C. HOPEWELL, M.D.
Effective chemotherapy has brought tuberculosis into the realm of diseases treated by general physicians in general hospitals. The primary drugs—isoniazid, para-amino-salicylic acid and streptomycin plus, in certain instances, ethambutol and pyrazinamide—are highly successful in treating patients with newly diagnosed tuberculosis. Two drug regimens containing isoniazid plus a companion drug are adequate for minimal or moderately advanced disease. Far-advanced disease is more effectively treated using three drugs including streptomycin or using the alternating regimen. Treatment of patients harboring organisms resistant to primary drugs is more difficult because of the low potency and increased toxicity of the secondary drugs. Secondary drug regimens should include at least three agents to which the organism is susceptible. Medication should not be discontinued because of vague complaints. Any suspected drug reaction must be carefully evaluated and documented.
Learn more about subscription options.
Register Now for a free account.
JOHNSTON RF, HOPEWELL PC. Chemotherapy of Pulmonary Tuberculosis. Ann Intern Med. 1969;70:359–367. doi: 10.7326/0003-4819-70-2-359
Download citation file:
Published: Ann Intern Med. 1969;70(2):359-367.
Infectious Disease, Mycobacterial Infections, Pulmonary Tuberculosis, Pulmonary/Critical Care.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only